Thomas Jefferson University

Ana Maria Lopez, MD, MPH, MACP, FRCP, has been appointed associate director for diversity, equity and inclusion at Sidney Kimmel Cancer Center — Jefferson Health.

Over the last decade, “telehealth” became a buzzword in conversations about health care innovation.

Andrew Chapman, DO, FACP, has been named director of Sidney Kimmel Cancer Center — Jefferson Health.

DALLAS — Neoadjuvant immunotherapy did not increase risk for complications among patients who underwent surgery for head and neck cancers, according to study results presented at American Head & Neck Society Annual Meeting.

Geographic gaps in cancer center catchment area coverage may be propagating disparities in cancer incidence and mortality, according to results of a study published in Cancer Epidemiology, Biomarkers and Prevention.

In a noninferiority randomized trial, the antidepressants amitriptyline and venlafaxine significantly reduced the number of migraine attacks per month, according to researchers.

Compared with conservative treatment, hematoma aspiration combined with platelet-rich plasma injection may shorten return to play and reduce recurrence rate among athletes with grade 2 hamstring strains, according to published results.

American Association for Cancer Research released a first-of-its-kind report detailing the impact of the COVID-19 pandemic on the cancer community, both in patient care and research practice.

For patients on left ventricular assist device support, the development of right HF at 3 months postimplantation increased the risk for repeated hospitalization and major adverse events, researchers reported.

Recent molecular science research may provide important insights as to why chimeric antigen receptor T-cell therapies for solid tumors have failed to achieve results that match those observed in blood cancers.